First Time Loading...
A

Aurisco Pharmaceutical Co Ltd
SSE:605116

Watchlist Manager
Aurisco Pharmaceutical Co Ltd
SSE:605116
Watchlist
Price: 23.35 CNY -1.44% Market Closed
Updated: May 17, 2024

Aurisco Pharmaceutical Co Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aurisco Pharmaceutical Co Ltd
Gross Profit Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
A
Aurisco Pharmaceutical Co Ltd
SSE:605116
Gross Profit
¥512.6m
CAGR 3-Years
20%
CAGR 5-Years
14%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Gross Profit
¥9.1B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Gross Profit
¥4.9B
CAGR 3-Years
17%
CAGR 5-Years
18%
CAGR 10-Years
20%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Gross Profit
¥19.5B
CAGR 3-Years
-8%
CAGR 5-Years
4%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Gross Profit
¥10.5B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
8%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Gross Profit
¥319.6m
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Aurisco Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
512.6m CNY

Based on the financial report for Dec 31, 2022, Aurisco Pharmaceutical Co Ltd's Gross Profit amounts to 512.6m CNY.

What is Aurisco Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
14%

Over the last year, the Gross Profit growth was 30%. The average annual Gross Profit growth rates for Aurisco Pharmaceutical Co Ltd have been 20% over the past three years , 14% over the past five years .